Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Correspondence:
View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cocho, D.
Right arrow Articles by Martí-Vilalta, J. -L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cocho, D.
Right arrow Articles by Martí-Vilalta, J. -L.
Related Collections
Right arrow All Clinical trials
Right arrow All Cerebrovascular disease/Stroke
Right arrow Infarction
NEUROLOGY 2005;64:719-720
© 2005 American Academy of Neurology
Brief Communications

Reasons for exclusion from thrombolytic therapy following acute ischemic stroke

D. Cocho, MD, R. Belvís, MD, J. Martí-Fàbregas, MD, L. Molina-Porcel, MD, J. Díaz-Manera, MD, A. Aleu, MD, J. Pagonabarraga, MD, D. García-Bargo, MD, A. Mauri, MD and J. -L. Martí-Vilalta, MD

From the Cerebrovascular Unit, Departments of Neurology (Drs. Cocho, Belvís, Martí-Fàbregas, Molina-Porcel, Díaz-Manera, Aleu, Pagonabarraga, García-Bargo, and Martí-Vilalta) and Emergency (Dr. Mauri), Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Spain.

Address correspondence and reprint requests to Dr. Dolores Cocho, Servicio de Neurología, Hospital de la Santa Creu i Sant Pau, Avda. Sant Antoni M. Claret 167, E-08025 Barcelona, Spain; E-mail: dcocho{at}hsp.santpau.es

Despite evidence for the efficacy of thrombolytic therapy in acute ischemic stroke, only 1 to 7% of patients receive this therapy. The authors sought to determine the reasons for exclusion from tissue plasminogen activator (tPA) in an acute setting and found avoidable causes in 18% of patients. Improvements in intrahospital coordination would increase the number of patients who might benefit from tPA treatment at the authors’ center.




This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
M.-K. Sun, J. Hongpaisan, T. J. Nelson, and D. L. Alkon
Poststroke neuronal rescue and synaptogenesis mediated in vivo by protein kinase C in adult brains
PNAS, September 9, 2008; 105(36): 13620 - 13625.
[Abstract] [Full Text] [PDF]

Home page
 Emerg. Med. J.Home page
M O McCarron, M Armstrong, and P McCarron
Potential for quality improvement of acute stroke management in a district general hospital
Emerg. Med. J., May 1, 2008; 25(5): 270 - 273.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
N. P. de la Ossa, J. Sanchez-Ojanguren, E. Palomeras, M. Millan, J. F. Arenillas, L. Dorado, C. Guerrero, S. Abilleira, and A. Davalos
Influence of the stroke code activation source on the outcome of acute ischemic stroke patients
Neurology, April 8, 2008; 70(15): 1238 - 1243.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
K. Nedeltchev, B. Schwegler, T. Haefeli, C. Brekenfeld, J. Gralla, U. Fischer, M. Arnold, L. Remonda, G. Schroth, and H. P. Mattle
Outcome of Stroke With Mild or Rapidly Improving Symptoms
Stroke, September 1, 2007; 38(9): 2531 - 2535.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
C. R. Baumann, R. W. Baumgartner, J. Gandjour, H.-C. von Budingen, A. M. Siegel, and D. Georgiadis
Good Outcomes in Ischemic Stroke Patients Treated With Intravenous Thrombolysis Despite Regressing Neurological Symptoms
Stroke, May 1, 2006; 37(5): 1332 - 1333.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
R.G. Gonzalez
Imaging-guided acute ischemic stroke therapy: From "time is brain" to "physiology is brain".
AJNR Am. J. Neuroradiol., April 1, 2006; 27(4): 728 - 735.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
P. Schestatsky, P. D. Picon, D. O. Kleindorfer, P. Khatri, I. Katzan, and D. Cocho
Reasons for exclusion from thrombolytic therapy following acute ischemic stroke
Neurology, December 13, 2005; 65(11): 1844 - 1844.
[Full Text] [PDF]

Home page
 CirculationHome page
Part 9: Adult Stroke
Circulation, December 13, 2005; 112(24_suppl): IV-111 - IV-120.
[Full Text] [PDF]

Home page
 StrokeHome page
E. E. Smith, A. R. Abdullah, I. Petkovska, E. Rosenthal, W. J. Koroshetz, and L. H. Schwamm
Poor Outcomes in Patients Who Do Not Receive Intravenous Tissue Plasminogen Activator Because of Mild or Improving Ischemic Stroke
Stroke, November 1, 2005; 36(11): 2497 - 2499.
[Abstract] [Full Text] [PDF]

Correspondence:

Read all Correspondence

Reasons for exclusion from thrombolytic therapy following acute ischemic stroke
Pedro Schestatsky, et al.
Neurology Online, 12 May 2005 [Full text]
Reasons for exclusion from thrombolytic therapy following acute ischemic stroke
Dawn O. Kleindorfer, et al.
Neurology Online, 12 May 2005 [Full text]
Reply to Kleindorfer et al
Dolores Cocho
Neurology Online, 12 May 2005 [Full text]
Reply to Schestatsky et al
Dolores Cocho
Neurology Online, 12 May 2005 [Full text]

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by AAN Enterprises, Inc.